BioCentury
ARTICLE | Clinical News

Firdapse amifampridine 3 regulatory update

September 3, 2012 7:00 AM UTC

The Scottish Medicines Consortium recommended against the use of Firdapse amifampridine from BioMarin on the National Health Service (NHS) in Scotland to treat Lambert-Eaton myasthenic syndrome (LEMS)...